MDWD — Mediwound Cashflow Statement
0.000.00%
Last trade - 00:00- $240.98m
- $216.61m
- $20.22m
Annual cashflow statement for Mediwound, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.2 | -13.6 | -19.6 | -6.72 | -30.2 |
| Depreciation | |||||
| Non-Cash Items | 1.27 | 3.23 | 13.7 | -7.39 | 13.8 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.061 | 0.162 | -7.24 | 2.34 | 1.27 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -6.89 | -8.92 | -11.9 | -10.5 | -13.6 |
| Capital Expenditures | -0.923 | -0.489 | -0.555 | -6.46 | -6.27 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 18.3 | 4.04 | 0.074 | -27.9 | -2.12 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 17.4 | 3.55 | -0.481 | -34.3 | -8.4 |
| Financing Cash Flow Items | -0.121 | -0.36 | -1.93 | -1.21 | -3.05 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.629 | -1.05 | 35.8 | 22.9 | 19.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.1 | -6.33 | 22.8 | -22 | -2.71 |